Investor

Avego Bioscience Capital

Last cheque observed Jun 2026; 8 cheques on record.

Deploying nowNew fund $60M, Apr 2026Private equity

Series ASeries BSeries D

Deploying now
80%of best year4cheques in 12 months, 8 on record
Since the last cheque152days00hrs00min00sec
Median round$140MRounds led1 of 8Mostly inUnited States, 63%
Pitch Avego Bioscience Capital

Avego Bioscience Capital highlights

  1. 01

    4 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 63% of its rounds

  3. 03

    Led 1 rounds

What they do

Type
Private equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first8 appearances

  1. 2026

    4 rounds

  2. Jun
    Memento MedicinesSeries A · GB · Avego Management$93MLed
  3. Feb
    Alveus Therapeutics Inc.Series A · US · Seroba Life Sciences$197MWith 8 others
  4. Jan
    Alveus TherapeuticsSeries A · US · Avego Management$160MWith 5 others
  5. Jan
    EpiBiologicsSeries B · US · Avego Management$107MWith 11 others
  6. 2025

    2 rounds

  7. Jul
    MapLight TherapeuticsSeries D · US · Avego Management$373MWith 8 others
  8. May
    CellCentricSeries C · GB · Avego Management$120MWith 3 others
  9. 2024

    2 rounds

  10. Nov
    Alentis TherapeuticsSeries D · CH · Avego Management$181MWith 11 others
  11. Nov
    TRex BioSeries B · US · Avego Management$84MWith 8 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration2 named

ARAlyssa RomanoChief Compliance Officer of the General PartneriFiling they signed
BVBalaji VenkataramanManaging Member of the General PartneriFiling they signed

We also hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Avego Bioscience Capital. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Avego Bioscience Capital put money into.

Quick answers about Avego Bioscience Capital

What does Avego Bioscience Capital invest in?

Avego Bioscience Capital invests most often at Series A and Series B (63% of the rounds on record).

How active is Avego Bioscience Capital?

8 investments on record, 4 of them in the last 12 months, and it led 1. The most recent was in Jun 2026.

What has Avego Bioscience Capital invested in recently?

Its most recent investments on record: Memento Medicines (Series A, Jun 2026), Alveus Therapeutics Inc. (Series A, Feb 2026) and Alveus Therapeutics (Series A, Jan 2026).

How big are Avego Bioscience Capital's cheques?

The median round it joins is $140M.

Does Avego Bioscience Capital lead rounds?

Sometimes: it led 1 of its 8 investments on record (13%).

Where does Avego Bioscience Capital invest?

Most of the companies it backs are in the United States (63%), the United Kingdom (25%) and Switzerland (13%).

Is Avego Bioscience Capital investing now?

Yes: it is actively investing, with 4 investments in the last 12 months.

Who does Avego Bioscience Capital invest alongside?

Most often Sanofi (4 rounds together), Forbion Capital Partners (3 rounds together) and Novo Holdings (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it